190 related articles for article (PubMed ID: 23477323)
1. Biomarkers for early detection of ovarian cancer.
Nguyen L; Cardenas-Goicoechea SJ; Gordon P; Curtin C; Momeni M; Chuang L; Fishman D
Womens Health (Lond); 2013 Mar; 9(2):171-85; quiz 186-7. PubMed ID: 23477323
[TBL] [Abstract][Full Text] [Related]
2. The bimanual ovarian palpation examination in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: Performance and complications.
Doroudi M; Kramer BS; Pinsky PF
J Med Screen; 2017 Dec; 24(4):220-222. PubMed ID: 27903809
[TBL] [Abstract][Full Text] [Related]
3. Screening for ovarian cancer.
Cragun JM
Cancer Control; 2011 Jan; 18(1):16-21. PubMed ID: 21273976
[TBL] [Abstract][Full Text] [Related]
4. HE4 in ovarian cancer: from discovery to clinical application.
Montagnana M; Danese E; Giudici S; Franchi M; Guidi GC; Plebani M; Lippi G
Adv Clin Chem; 2011; 55():1-20. PubMed ID: 22126021
[TBL] [Abstract][Full Text] [Related]
5. Proteomics and biomarkers for ovarian cancer diagnosis.
Zhang B; Barekati Z; Kohler C; Radpour R; Asadollahi R; Holzgreve W; Zhong XY
Ann Clin Lab Sci; 2010; 40(3):218-25. PubMed ID: 20689132
[TBL] [Abstract][Full Text] [Related]
6. An overview of biomarkers for the ovarian cancer diagnosis.
Zhang B; Cai FF; Zhong XY
Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):119-23. PubMed ID: 21632171
[TBL] [Abstract][Full Text] [Related]
7. Multiple biomarker panels for early detection of ovarian cancer.
Yurkovetsky ZR; Linkov FY; E Malehorn D; Lokshin AE
Future Oncol; 2006 Dec; 2(6):733-41. PubMed ID: 17155900
[TBL] [Abstract][Full Text] [Related]
8. Discovery and application of protein biomarkers for ovarian cancer.
Gagnon A; Ye B
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):9-13. PubMed ID: 18196999
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers for screening, diagnosis, and monitoring of ovarian cancer.
Kobayashi E; Ueda Y; Matsuzaki S; Yokoyama T; Kimura T; Yoshino K; Fujita M; Kimura T; Enomoto T
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):1902-12. PubMed ID: 22962405
[TBL] [Abstract][Full Text] [Related]
10. Early detection of ovarian cancer.
Badgwell D; Bast RC
Dis Markers; 2007; 23(5-6):397-410. PubMed ID: 18057523
[TBL] [Abstract][Full Text] [Related]
11. Ovarian cancer biomarkers: current state and future implications from high-throughput technologies.
Leung F; Diamandis EP; Kulasingam V
Adv Clin Chem; 2014; 66():25-77. PubMed ID: 25344985
[TBL] [Abstract][Full Text] [Related]
12. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic markers for early detection of ovarian cancer.
Visintin I; Feng Z; Longton G; Ward DC; Alvero AB; Lai Y; Tenthorey J; Leiser A; Flores-Saaib R; Yu H; Azori M; Rutherford T; Schwartz PE; Mor G
Clin Cancer Res; 2008 Feb; 14(4):1065-72. PubMed ID: 18258665
[TBL] [Abstract][Full Text] [Related]
14. Ovarian cancer: biomarker proteomic diagnosis in progress.
Zhang Y; Guo B; Bi R
Appl Biochem Biotechnol; 2012 Oct; 168(4):910-6. PubMed ID: 22945560
[TBL] [Abstract][Full Text] [Related]
15. Molecular signatures of ovarian cancer: from detection to prognosis.
Walsh CS; Karlan BY
Mol Diagn Ther; 2010 Feb; 14(1):13-22. PubMed ID: 20121286
[TBL] [Abstract][Full Text] [Related]
16. Validation of serum biomarkers for detection of early-stage ovarian cancer.
Nosov V; Su F; Amneus M; Birrer M; Robins T; Kotlerman J; Reddy S; Farias-Eisner R
Am J Obstet Gynecol; 2009 Jun; 200(6):639.e1-5. PubMed ID: 19285648
[TBL] [Abstract][Full Text] [Related]
17. Progress and challenges in screening for early detection of ovarian cancer.
Jacobs IJ; Menon U
Mol Cell Proteomics; 2004 Apr; 3(4):355-66. PubMed ID: 14764655
[TBL] [Abstract][Full Text] [Related]
18. Searching for a system: the quest for ovarian cancer biomarkers.
Rodland KD; Maihle NJ
Cancer Biomark; 2010-2011; 8(4-5):223-30. PubMed ID: 22045355
[TBL] [Abstract][Full Text] [Related]
19. Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?
van der Velde NM; Mourits MJ; Arts HJ; de Vries J; Leegte BK; Dijkhuis G; Oosterwijk JC; de Bock GH
Int J Cancer; 2009 Feb; 124(4):919-23. PubMed ID: 19035463
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer screening.
Rosenthal A; Jacobs I
Semin Oncol; 1998 Jun; 25(3):315-25. PubMed ID: 9633843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
